Skip to main content
. 2020 Feb 26;245(5):465–476. doi: 10.1177/1535370220909309

Figure 3.

Figure 3.

Metabolism-based therapy compromises CSC properties. Metabolism-based therapeutic strategies targeting pivotal metabolic pathways that can be exploited in preclinical and clinical settings. Specific metabolic inhibitors that can overwhelm stem cell properties may halt disease recurrence, attenuate CSC dissemination, and dampen the capacity of spawning metastasis of cancer cells. (A color version of this figure is available in the online journal.)